Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Nijole Bernaitis"'
Publikováno v:
Nutrients, Vol 8, Iss 9, p 578 (2016)
Background: Warfarin is a leading anticoagulant in the management of atrial fibrillation (AF) and deep vein thrombosis (DVT). Drug interactions influence the safety of warfarin use and while extensive literature exists regarding the effect on warfari
Externí odkaz:
https://doaj.org/article/9e7c41db673c4ef8b36152d6f34d9b3d
Autor:
Susan Hall, Santosh Rudrawar, Matthew Zunk, Nijole Bernaitis, Devinder Arora, Catherine M McDermott, Shailendra Anoopkumar-Dukie
Publikováno v:
Antioxidants, Vol 5, Iss 3, p 22 (2016)
Radiation therapy is a highly utilized therapy in the treatment of malignancies with up to 60% of cancer patients receiving radiation therapy as a part of their treatment regimen. Radiation therapy does, however, cause a wide range of adverse effects
Externí odkaz:
https://doaj.org/article/10bf9d45f65c4c00bcb0e72a1b45440c
Publikováno v:
International Journal of Pharmacy Practice. 30:273-278
Objectives In Australia, pharmacists may become authorised immunisers by obtaining additional credentialling from certified providers. Some Australian Universities are providing externally accredited immunisation training to final year pharmacy stude
Autor:
Liam King, Nijole Bernaitis, David Christie, Russ Chess-Williams, Donna Sellers, Catherine McDermott, Wendy Dare, Shailendra Anoopkumar-Dukie
Publikováno v:
Journal of clinical medicine. 11(19)
Prostate cancer (PCa) is the second most commonly diagnosed cancer worldwide. Radiotherapy remains one of the first-line treatments in localised disease and may be used as monotherapy or in combination with other treatments such as androgen deprivati
Publikováno v:
Heart, Lung and Circulation. 29:e222-e230
Background Anticoagulation reduces stroke risk in patients with atrial fibrillation (AF) but under-prescribing in eligible patients has been commonly reported. Introduction of the direct acting oral anticoagulants (DOACs) was considered to potentiall
Publikováno v:
Journal of Thrombosis and Thrombolysis. 50:614-618
Oral anticoagulation options for patients with venous thromboembolism (VTE) include vitamin K antagonists like warfarin. Good warfarin control is linked to outcomes of therapy, and the SAMe–TT2R2 model has been reported to predict control in atrial
Autor:
Ellen Simpson, Sohil Khan, Shailendra Anoopkumar-Dukie, Nijole Bernaitis, Karly Forster, Gary Grant
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 30(4)
Supportive Care in Cancer: This literature review examines the provision of an education on pharmacologically active complementary and alternative medicines (CAMs), to people with cancer, their carers and oncology health professionals. Supportive Car
Publikováno v:
Orthopaedics & Traumatology: Surgery & Research. 105:1073-1077
Background Tranexamic acid (TXA) has long been used to reduce blood loss associated with total knee arthroplasty (TKA). Debate remains over the best administration route with limited data comparing regimes including, to date, no studies investigating
Publikováno v:
Journal of thrombosis and thrombolysis. 52(4)
There are now anticoagulant choices with proposed advantages of non-vitamin K oral anticoagulants (NOACs) over warfarin being less routine monitoring and less drug interactions. Interacting medication can impact the efficacy and safety of anticoagula
Autor:
Nijole Bernaitis, Shailendra Anoopkumar-Dukie, Narong Puttasung, Andrew K. Davey, Tony Badrick
Publikováno v:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 30(4)
Objectives Warfarin remains widely used with a time in therapeutic range (TiTR) above 65% recommended for best outcomes. Patients not achieving or maintaining this warfarin control may be better suited to alternate anticoagulants. Despite this, there